Search - tctmd.com

Displaying 481 - 500 of 1300

Sort: Relevancy | Date

News Daily News

一项研究探讨了在ACS患者中使用普拉格雷、氯吡格雷的真实情况

May 12, 2015

News Daily News

Un Estudio Explora el Uso en el ‘Mundo Real’ de Prasugrel vs. Clopidogrel en el Manejo del SCA

May 12, 2015

News Daily News

Study Explores ‘Real-World’ Use of Prasugrel vs Clopidogrel in ACS

May 12, 2015

News Daily News

替卡格雷比氯吡格雷更快地抑制接受临时PCI的低风险ACS患者的血小板活性

Todd Neale

May 11, 2015

News Daily News

Ticagrelor Suprime Más Rápidamente la Inhibición Plaquetaria que Clopidogrel en Pacientes SCA de Riesgo Bajo durante la realización de PCI Ad Hoc

Todd Neale

May 11, 2015

News Daily News

Ticagrelor More Rapidly Suppresses Platelet Activity Than Clopidogrel for Low-Risk ACS Patients During Ad Hoc PCI

Todd Neale

May 11, 2015

Presentation

PROMETHEUS: Clinical Assessment of ACS Patients Managed With PCI and Treated With Prasugrel or Clopidogrel

Presenter: Usman Baber

May 11, 2015

Presentation

Ticagrelor vs Clopidogrel in Troponin-Negative ACS Patients Undergoing Ad Hoc PCI

Presenter: Roxana Mehran

May 08, 2015

News Industry News

Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients

May 07, 2015

News Daily News

双联抗血小板治疗与高危PAD患者的更佳结果有联系

Leah Lawrence

April 29, 2015

News Daily News

ISAR-TRIPLE 已发布：6 周与 6 个月三联疗法比较并无净收益

April 29, 2015

News Daily News

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

April 29, 2015

News Daily News

ISAR-TRIPLE Publicado: No hay Beneficio Neto durante 6 Semanas frente a 6 Meses a Tratamiento Triple

April 29, 2015

News Daily News

El Tratamiento Antiplaquetario Doble se asoció a Mejores Resultados en Pacientes EAP de Alto Riesgo

Leah Lawrence

April 29, 2015

News Daily News

Dual Antiplatelet Therapy Tied to Better Outcomes in High Risk PAD Patients

Leah Lawrence

April 29, 2015

News Daily News

活化凝血时间可能预测单纯使用肝素的 PCI 的缺血事件

L.A. McKeown

April 28, 2015

News Daily News

El Tiempo de Coagulación Activado podría Predecir los Episodios Isquémicos en Pacientes PCI a Tratamiento Solo con Heparina

L.A. McKeown

April 28, 2015

News Daily News

Activated Clotting Time May Predict Ischemic Events in PCI Patients on Heparin Alone

L.A. McKeown

April 28, 2015

Presentation

Activated Clotting Time (ACT) and Outcomes During PCI for NSTEMI: Insights from FUTURA OASIS-8

Presenter: Gregory Ducrocq

April 24, 2015

Presentation

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After DES Implantation

Presenter: K.A. Fiedler

April 22, 2015

Advertisement

一项研究探讨了在ACS患者中使用普拉格雷、氯吡格雷的真实情况

Un Estudio Explora el Uso en el ‘Mundo Real’ de Prasugrel vs. Clopidogrel en el Manejo del SCA

Study Explores ‘Real-World’ Use of Prasugrel vs Clopidogrel in ACS

替卡格雷比氯吡格雷更快地抑制接受临时PCI的低风险ACS患者的血小板活性

Ticagrelor Suprime Más Rápidamente la Inhibición Plaquetaria que Clopidogrel en Pacientes SCA de Riesgo Bajo durante la realización de PCI Ad Hoc

Ticagrelor More Rapidly Suppresses Platelet Activity Than Clopidogrel for Low-Risk ACS Patients During Ad Hoc PCI

PROMETHEUS: Clinical Assessment of ACS Patients Managed With PCI and Treated With Prasugrel or Clopidogrel

Ticagrelor vs Clopidogrel in Troponin-Negative ACS Patients Undergoing Ad Hoc PCI

Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients

双联抗血小板治疗与高危PAD患者的更佳结果有联系

ISAR-TRIPLE 已发布：6 周与 6 个月三联疗法比较并无净收益

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

ISAR-TRIPLE Publicado: No hay Beneficio Neto durante 6 Semanas frente a 6 Meses a Tratamiento Triple

El Tratamiento Antiplaquetario Doble se asoció a Mejores Resultados en Pacientes EAP de Alto Riesgo

Dual Antiplatelet Therapy Tied to Better Outcomes in High Risk PAD Patients

活化凝血时间可能预测单纯使用肝素的 PCI 的缺血事件

El Tiempo de Coagulación Activado podría Predecir los Episodios Isquémicos en Pacientes PCI a Tratamiento Solo con Heparina

Activated Clotting Time May Predict Ischemic Events in PCI Patients on Heparin Alone

Activated Clotting Time (ACT) and Outcomes During PCI for NSTEMI: Insights from FUTURA OASIS-8

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After DES Implantation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content